Gene · 1311
Papers2,758
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,758
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Association of inflammatory, genetic, and epigenetic markers with Kellgren-Lawrence grading in post-traumatic osteoarthritis of knee: A protocol. | World J Exp Med | 2025 | 41497677 | PubTator, text mining | PubMed |
| Elevated MMP9 Expression-A Potential In Vitro Biomarker for COMPopathies. | Int J Mol Sci | 2025 | 41465495 | PubTator, text mining | PubMed |
| Serum trace element and mineral levels and fecal microbiota in relation to cartilage damage in rheumatoid arthritis patients. | J Trace Elem Med Biol | 2025 | 41192168 | PubTator, text mining | PubMed |
| From Protein Misfolding to Extracellular Matrix Disorganisation: Understanding Disease Pathology in Rare Skeletal Dysplasias. | Int J Mol Sci | 2025 | 41155349 | PubTator, text mining | PubMed |
| A thermo-sensitive peptide hydrogel loaded with paclitaxel and antimony nanosheets for synergistic photothermal-chemotherapeutic treatment of breast cancer. | Front Pharmacol | 2025 | 41142230 | PubTator, text mining | PubMed |
| Detecting Biomarkers of Radiation Pneumonitis in Exhaled Breath During Chemoradiotherapy for Stage III Non-small Cell Lung Cancer: Results of a Prospective Feasibility Study. | Cureus | 2025 | 41133090 | PubTator, text mining | PubMed |
| Biomechanical and biological features of hyaluronic acid in combination with chondroitin and platelet rich plasma for regenerative medicine applications. | Front Bioeng Biotechnol | 2025 | 41126931 | PubTator, text mining | PubMed |
| COMP Is a Biomarker of Cartilage Destruction, Extracellular Matrix and Vascular Remodeling and Tissue Repair. | Int J Mol Sci | 2025 | 41009743 | PubTator, text mining | PubMed |
| Intraoperative Biologization of β-TCP and PCL-TCP by Autologous Proteins. | J Funct Biomater | 2025 | 41003411 | PubTator, text mining | PubMed |
| Current landscape of plasma proteomics from technical innovations to biological insights and biomarker discovery. | Commun Chem | 2025 | 40999057 | PubTator, text mining | PubMed |
| Musculoskeletal Complications in COVID-19: Exploring the Role of Key Biomarkers. | Int J Mol Sci | 2025 | 40943488 | PubTator, text mining | PubMed |
| Heightened innate immunity may trigger chronic inflammation, fatigue and post-exertional malaise in ME/CFS. | NPJ Metab Health Dis | 2025 | 40903540 | PubTator, text mining | PubMed |
| Spatial transcriptomic profiling of the human aortic valve reveals cellular sex differences near sites of calcification. | bioRxiv | 2025 | 40894684 | PubTator, text mining | PubMed |
| Hepatocellular carcinoma stem cells: the current state of small molecule-based inhibitors. | Cell Death Dis | 2025 | 40890130 | PubTator, text mining | PubMed |
| Pharmacist-Driven Chondroprotection in Osteoarthritis: A Multifaceted Approach Using Patient Education, Information Visualization, and Lifestyle Integration. | Pharmacy (Basel) | 2025 | 40863703 | PubTator, text mining | PubMed |
| Plasma exosomes from individuals with type 2 diabetes drive breast cancer aggression in patient-derived organoids. | Commun Biol | 2025 | 40858992 | PubTator, text mining | PubMed |
| Short histological kaleidoscope - recent findings in histology. Part V. About tendons, ligaments, and cartilages. | Rom J Morphol Embryol | 2025 | 40851240 | PubTator, text mining | PubMed |
| A systematic review of the association between ultrasound-detected features and laboratory inflammatory biomarkers in hand osteoarthritis. | Ann Med | 2025 | 40836380 | PubTator, text mining | PubMed |
| Lymphadenectomy in upper tract urothelial carcinoma: Clinical insights and controversies (Review). | Oncol Rep | 2025 | 40808341 | PubTator, text mining | PubMed |
| Oral enzyme combination therapy reduces systemic inflammation, urinary CTXII and pain in knee osteoarthritis: a proof-of-mechanism, randomised, crossover, double-blind, placebo-controlled trial. | RMD Open | 2025 | 40803821 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1311/papers?page=3